Cardinal Health CAH
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
Cardinal Health (CAH) Business Model and Operations Summary
Cardinal Health is one of three leading pharmaceutical wholesalers in the us, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and McKesson, the three comprise well over 90% of the us pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Key Insights
Cardinal Health (CAH) Core Market Data and Business Metrics
Latest Closing Price
$137.13Market Cap
$33.50 BillionTotal Outstanding Shares
243.57 Million SharesTotal Employees
48,000Dividend
$0.51 Per Share QuarterlyIPO Date
September 7, 1994SIC Description
Wholesale-drugs, Proprietaries & Druggists' SundriesPrimary Exchange
New York Stock ExchangeHeadquarters
7000 Cardinal Place, Dublin, OH, 43017
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Investing Activities | $-2.75 Billion |
| Net Cash Flow From Financing Activities, Continuing | $1.96 Billion |
| Exchange Gains/Losses | $-13 Million |
| Net Cash Flow From Operating Activities | $8 Million |
| Net Cash Flow From Financing Activities | $1.96 Billion |
| Net Cash Flow, Continuing | $-774 Million |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Income/Loss Attributable To Noncontrolling Interest | $1 Million |
| Other Operating Expenses | $647 Million |
| Gross Profit | $7.63 Billion |
| Operating Expenses | $5.74 Billion |
| Net Income/Loss Available To Common Stockholders, Basic | $1.31 Billion |
| Basic Average Shares | $485 Million |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss | $1.29 Billion |
| Other Comprehensive Income/Loss | $-25 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $1 Million |
| Other Comprehensive Income/Loss Attributable To Parent | $-25 Million |
| Comprehensive Income/Loss Attributable To Parent | $1.29 Billion |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Liabilities And Equity | $47.00 Billion |
| Current Assets | $35.76 Billion |
| Assets | $47.00 Billion |
| Accounts Receivable | $12.37 Billion |
| Other Current Assets | $6.48 Billion |
| Accounts Payable | $31.30 Billion |
Historical Dividends
Current dividend: $0.51 Per Share Quarterly
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| Feb 3, 2025 | Apr 15, 2025 | Apr 1, 2025 | $0.5056 | Quarterly |
| Nov 5, 2024 | Jan 15, 2025 | Jan 2, 2025 | $0.5056 | Quarterly |
| Aug 15, 2024 | Oct 15, 2024 | Oct 1, 2024 | $0.5056 | Quarterly |
| May 7, 2024 | Jul 15, 2024 | Jul 1, 2024 | $0.5056 | Quarterly |
| Feb 6, 2024 | Apr 15, 2024 | Apr 1, 2024 | $0.5006 | Quarterly |
| Nov 14, 2023 | Jan 15, 2024 | Jan 2, 2024 | $0.5006 | Quarterly |